Dynamic Hydrogels
Dynamic Hydrogels
Christopher M. Madl,* Yu Xin Wang, Colin A. Holbrook, Shiqi Su, Xuechen Shi, Fitzroy J. Byfield,
Gwendoline Wicki, Iris A. Flaig, Helen M. Blau*
Supporting text
Figures S1 to S10
SI References
1
Supporting Information Text
1. Supporting Note 1
Our hydrogel culture platforms were designed to mimic key biophysical aspects of the cell
microenvironment during the process of stem cell activation following tissue damage. After injury,
the multinucleated muscle fiber degenerates, leaving a hollow tube of basal lamina ECM, a
structure that has been termed a “ghost fiber” (1). Thus, as MuSCs break quiescence and
activate, they remain attached to the basal lamina, even though the injury has disrupted the cell-
cell contacts with the muscle fiber that exist in resting tissue. As the residual ECM tube is a quasi-
two-dimensional (2D) environment, culturing MuSCs on the 2D surface of hydrogels whose
stiffness resembles that of the muscle ECM is a reasonable model system for the early stages of
muscle repair when cell-ECM adhesions dominate. The composition of the ECM is also tightly
regulated during muscle repair, serving as an important signal that regulates myogenic
progression in MuSCs (2–4). The early stages of muscle repair are characterized by high
expression of laminin isoforms (3), and our previous work has confirmed that culturing MuSCs on
laminin-functionalized surfaces promotes MuSC expansion in vitro and engraftment in vivo (5, 6).
Thus, the hydrogels used in this study were functionalized with laminin to best mimic the
dominant ECM composition during MuSC activation. This simplified system enables causal
relationships to be more readily determined due to the limited number of variables, but this
advantage comes at the expense of the complex and heterogeneous environment present during
muscle regeneration in vivo. Future work may leverage 3D organotypic culture systems (7) in
combination with advanced biomaterials approaches to more completely model MuSC-mediated
regeneration in vitro.
2.1. Materials
Precursors and solvents for chemical synthesis were purchased from Sigma-Aldrich,
Fisher Scientific, Acros Organics, or Tokyo Chemical Industry (TCI) and used without further
purification, unless otherwise noted. Multi-arm poly(ethylene glycol) (PEG) precursor materials
were purchased from JenKem Technology USA. Cell culture reagents were purchased from
Thermo Fisher Scientific, unless otherwise noted.
2
as described below in the Detailed Synthetic Procedures (12). Azide-functionalized PEGs were
prepared by reacting 8-arm PEG-amine with activated NHS ester azides under standard amide
coupling conditions, as previously described (6, 8, 13). BCN- and pODIBO-functionalized sulfated
PEGs were prepared by sequentially reacting 4-arm or 8-arm PEG-amine with cysteic acid and
BCN-NHS/p-ODIBO-NHS as in our previous work (6). All synthesized PEGs were dialyzed
against MilliQ-grade water and lyophilized prior to use. Azide-functionalized laminin-111 was
prepared by reacting purified laminin with N3-PEG-NHS following our previous protocols for
laminin functionalization (5, 6).
3
The laminin content in the hydrogels was measured by incorporating fluorescently
labeled laminin into the hydrogels. Laminin-PEG-N3 was reacted with a 50-fold molar excess of
Sulfo-Cyanine5-NHS ester (Lumiprobe) for 8 hours at room temperature with agitation. The
labeled laminin was then dialyzed (20 kDa MWCO) against PBS to remove unreacted dye. The
Cy5-labeled laminin-PEG-N3 was used to fabricate gels as described above, which were then
equilibrated in PBS before light exposure and imaging. The gels were imaged on a Zeiss LSM
900 confocal microscope. Soft static gels containing labeled laminin were exposed to the same
dose of UV light as the softening and stiffening gels to account for any changes in fluorescence
due to photobleaching of the fluorophore.
4
maximize cell-substrate interactions throughout the course of the experiment. Following our
previous protocol (6), MuSCs were cultured in FluoroBrite DMEM with 15% FBS, L-glutamine,
sodium pyruvate, non-essential amino acids, penicillin/streptomycin, and 2.5 ng/mL FGF-2. For
experiments using the myogenin Sun1-GFP reporter MuSCs, the medium was supplemented
daily with 4-hydroxytamoxifen (1 μM). Media was replaced on days 3 and 5. For
mechanotransduction inhibitor experiments, cells were treated with DMSO vehicle, rhosin (30
μM), NSC23766 (50 μM), or verteporfin (4 μM) at the time of seeding and refreshed on days 1
and 2 of culture before being washed out at day 3. The concentrations of inhibitors were selected
based on previously published results indicating efficacy without impairing cell adhesion or
viability (17–19). For dynamic hydrogel softening and stiffening experiments, gels were exposed
to 365 nm light (~450 mW/cm2) for four minutes. For EdU incorporation experiments, F-ara-EdU
was added to the culture medium on day 7, 6 hours prior to fixation, at a final concentration of 10
μM.
5
were imaged on a Zeiss AxioObserver inverted microscope with a 7-channel ZEISS Colibri 7 light
source for multichannel fluorescence imaging. Tiled image regions were collected near the center
of the gels. Images were deconvolved and stitched using our previously published GPU-
accelerated image processing pipeline (6, 22). For quantitative analysis, images were segmented
and analyzed using either Cell Profiler or the CellSeg pipeline (23).
6
pipetted into an azide-functionalized 12-well plate (prepared as described previously (6)), and
then a 12 mm glass coverslip that had been passivated with Sigmacote (Sigma-Aldrich) was
placed on top of the PEG mixture droplet. The plate was then incubated at 37°C for 30 minutes to
allow the gels to crosslink. Gels were then incubated for 1 hour in PBS containing 10% Pen/Strep
and 1x Antioxidant Supplement (Sigma-Aldrich, 1000x), allowing swelling and removal of the top
coverslip. After several washes with PBS to remove excess antibiotic, cells resuspend in
FluoroBrite DMEM culture medium containing 1x antioxidant were seeded at 25,000 cells/well.
Cells were allowed to adhere for 24 hours before the phototoxicity experiments were performed.
For conditions testing soluble methylene blue, media containing 10 μM methylene blue was
added to the cells prior to light illumination. For conditions testing tethered IRDye 700DX, cells
were seeded either on gels that contained no dye or gels with 20 μM tethered IRDye 700DX. In
experiments assessing toxicity of light-triggered stiffening, gels were illuminated with a light
emitting diode (LED) at 660 nm (methylene blue) or 680 nm (IRDye 700DX), placed underneath
the gel at a distance of 2 cm. Culture medium was changed immediately after illumination. 24
hours after dye/light exposure, cells were incubated in calcein-AM (1 µM) and ethidium
homodimer (1 µM) diluted in FluoroBrite DMEM for 30 minutes. The staining solution was
replaced with fresh FluoroBrite DMEM, and the samples were imaged. Four images per gel were
captured with a Keyence inverted fluorescence microscope (BZ X-710) at 4x magnification, using
the GFP (Ex: 470/40, DM 495, BA 525/50, OP-87763) and the TRITC (Ex: 545/25, DM 565, BA
605/70, OP-87764) filter sets, as well as in brightfield. A manual count of green cells (alive) and
red nuclei (dead) was performed to calculate the cell viability ratio.
7
2.11. Statistical analysis
At least 3 independent replicates were used for each experiment. Statistical analysis was
performed using GraphPad Prism 8. For population level data, data sets were assumed to follow
normal distributions, and the following analyses were used: comparisons between two
experimental groups with a single varying parameter were performed using two-tailed Student’s t-
tests and comparisons among more than two experimental groups with a single varying
parameter were performed using one-way analysis of variance (ANOVA) with Tukey post-hoc
testing. For single cell immunofluorescence data, the data were not normally distributed, so
comparisons among more than two experimental groups with a single varying parameter were
performed using nonparametric Kruskal-Wallis tests with Dunn’s multiple comparisons
corrections. Corrected p-values of less than 0.05 were considered statistically significant.
8
3. Detailed Synthetic Procedures
NMR (500 MHz, CDCl3) δ ppm 4.45 (d, J = 8.3 Hz, 2H), 2.84 (s, 4H),
2.27 (m, 6H), 1.56 (m, 2H), 1.50 (m, 1H), 1.06 (m, 2H). 13C NMR (126
MHz, CDCl3) δ ppm 168.70, 151.59, 98.66, 70.32, 28.93, 25.44, 21.28,
20.67, 17.13. Rf 0.50 (1:1 hexanes:EtOAc).
9
3.5. Synthesis of Photo-SPAAC Linker (pODIBO-NHS)
The photo-activatable strained cyclooctyne (pODIBO) precursor was synthesized by adapting
previously published synthetic routes for the pODIBO core structure (28, 29).
3.5.1. 3-((tert-butyldimethylsilyl)oxy)benzaldehyde
3-hydroxybenzaldehyde (15 g, 123 mmol, 1 eq.) and imidazole (8.36 g, 123 mmol, 1 eq.) were
added to a 1 L round bottom flask with a stir bar and dissolved in anhydrous dichloromethane
(400 mL). tert-butyldimethylsilyl chloride (22.22 g, 147 mmol, 1.2 eq.) was added. The flask was
purged with nitrogen, and the reaction was allowed to proceed at room temperature for 3 h. The
mixture was filtered to remove the white precipitate, concentrated by rotary evaporation, and
purified by silica flash chromatography, eluting with 10:1 hexanes:ethyl acetate. Fractions
containing the desired product were identified by TLC, combined, and concentrated in vacuo to
afford the product as a faint yellow oil (27.26 g, 115 mmol, 93.5% yield). 1H NMR (500 MHz,
CDCl3) δ ppm 9.96 (s, 1H), 7.48 (dt, J = 7.5, 1.3 Hz, 1H), 7.41 (t, J = 7.8 Hz, 1H), 7.34 (dd, J =
2.6, 1.6 Hz, 1H), 7.11 (m, 1H), 1.00 (s, 9H), 0.23 (s, 6H). 13C NMR (126 MHz, CDCl3) δ ppm
192.07, 156.36, 137.88, 130.05, 126.52, 123.54, 119.83, 25.58, 18.17, -4.46. Rf 0.58 (10:1
hexanes:EtOAc).
10
3.5.2. (3-((tert-butyldimethylsilyl)oxy)phenyl)methanol
11
3.5.3. tert-butyl(3-((4-(tert-butyl)phenoxy)methyl)phenoxy)dimethylsilane
12
3.5.4. 3-(tert-butyl)-9-((tert-butyldimethylsilyl)oxy)dibenzo[b,f]cyclopropa[d]oxocin-1(7H)-
one
Aluminum chloride (2.54 g, 19 mmol, 1 eq.) was suspended in anhydrous dichloromethane (450
mL) in a 1 L round bottom flask with a stir bar. A solution of tetrachlorocyclopropene (3.43 g, 19
mmol, 1 eq.) in anhydrous dichloromethane (5 mL) was added to the stirring suspension, and the
flask was purged with nitrogen. After reacting at room temperature for 15 minutes, the mixture
was cooled in a dry ice/isopropanol bath. A solution of tert-butyl(3-((4-(tert-
butyl)phenoxy)methyl)phenoxy)dimethylsilane (7.00 g, 19 mmol, 1 eq.) in anhydrous
dichloromethane (20 mL) was added dropwise to the reaction mixture over the course of 10
minutes. The mixture was allowed to react in dry ice/isopropanol for 3 h, warm to room
temperature, and react for an additional 30 minutes. The reaction was quenched by addition of
5% aqueous hydrochloric acid (150 mL), and the organic layer was separated. The organic layer
was washed with brine, dried over magnesium sulfate, filtered, and concentrated by rotary
evaporation. The residue was purified by silica flash chromatography, eluting with
dichloromethane to 50:1 dichloromethane:methanol. Fractions containing the desired product
were combined and concentrated in vacuo to afford the product as an amorphous light yellow
solid (2.24 g, 5.3 mmol, 27.9% yield). A second run of the reaction using 3.35 g (9.0 mmol) of
starting material afforded 1.40 g (3.3 mmol, 36.7% yield) of purified product. 1H NMR (500 MHz,
CDCl3) δ ppm 7.97 (d, J = 1.7 Hz, 1H), 7.93 (d, J = 8.8 Hz, 1H), 7.52 (dd, J = 8.4, 1.8 Hz, 1H),
7.22 (d, J = 8.5 Hz, 1H), 6.99 (m, 2H), 5.27 (d, J = 11.7 Hz, 1H), 4.79 (d, J = 12.5 Hz, 1H), 1.37
(s, 9H), 1.02 (s, 9H), 0.28 (s, 6H). 13C NMR (126 MHz, CDCl3) δ ppm 162.25, 160.63, 159.77,
147.99, 140.95, 135.57, 132.26, 131.18, 130.99, 128.14, 122.29, 121.92, 120.65, 117.88, 116.65,
78.62, 34.51, 31.25, 25.50, 18.19, -4.33. Rf 0.43 (50:1 DCM:MeOH).
13
3.5.5. 3-(tert-butyl)-9-hydroxydibenzo[b,f]cyclopropa[d]oxocin-1(7H)-one
14
3.5.6. tert-butyl 3-(2-((3-(tert-butyl)-1-oxo-1,7-dihydrodibenzo[b,f]cyclopropa[d]oxocin-9-
yl)oxy)ethoxy)propanoate
3.5.7. 3-(2-((3-(tert-butyl)-1-oxo-1,7-dihydrodibenzo[b,f]cyclopropa[d]oxocin-9-
yl)oxy)ethoxy)propanoic acid
tert-butyl 3-(2-((3-(tert-butyl)-1-oxo-1,7-dihydrodibenzo[b,f]cyclopropa[d]oxocin-9-
yl)oxy)ethoxy)propanoate (2.23 g, 4.66 mmol, 1 eq.) was dissolved in 15 mL dichloromethane
and added to a 50 mL round bottom flask with a stir bar. Trifluoroacetic acid (6 mL) was added to
the stirring solution, and the reaction was allowed to proceed at room temperature for 2 h. The
reaction mixture was washed with water (2 × 15 mL) and brine (15 mL), dried over magnesium
sulfate, filtered, and concentrated in vacuo to afford the product as a white solid (1.07 g, 2.53
mmol, 54.3% yield). 1H NMR (500 MHz, DMSO-d6) δ ppm 7.85 (d, J = 8.5 Hz, 1H), 7.78 (d, J =
2.7 Hz, 1H), 7.64 (dd, J = 8.5, 2.4 Hz, 1H), 7.35 (d, J = 2.4 Hz, 1H), 7.30 (d, J = 8.5, 1H), 7.18
(dd, J = 8.5, 2.7 Hz, 1H), 5.37 (d, J = 12.2 Hz, 1H), 4.88 (d, J = 12.5 Hz, 1H), 4.24 (m, 2H), 3.76
(m, 2H), 3.68 (t, J = 6.2 Hz, 2H), 2.47 (t, J = 6.3 Hz, 2H), 1.33 (s, 9H).
15
3.5.8. 2,5-dioxopyrrolidin-1-yl 3-(2-((3-(tert-butyl)-1-oxo-1,7-
dihydrodibenzo[b,f]cyclopropa[d]oxocin-9-yl)oxy)ethoxy)propanoate (pODIBO-NHS)
3-(2-((3-(tert-butyl)-1-oxo-1,7-dihydrodibenzo[b,f]cyclopropa[d]oxocin-9-yl)oxy)ethoxy)propanoic
acid (1.07 g, 2.53 mmol, 1 eq.) was suspended in anhydrous acetonitrile (25 mL) in a 50 mL
round bottom flask with a stir bar. N-hydroxysuccinimide (0.44 g, 3.82 mmol, 1.5 eq.), and N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.73 g, 3.82 mmol, 1.5 eq.) were
sequentially added to the stirring mixture, and the flask was purged with nitrogen. The reaction
was allowed to proceed overnight at room temperature under a nitrogen atmosphere. The
reaction mixture was filtered to remove a white precipitate and concentrated by rotary evaporation
to remove the acetonitrile. The residue was dissolved in dichloromethane (50 mL), washed with
water (2 × 50 mL) and brine (50 mL), dried over magnesium sulfate, filtered, and concentrated in
vacuo to afford the product as a white solid (1.11 g, 2.14 mmol, 84.6% yield). 1H NMR (500 MHz,
CDCl3) δ ppm 7.94 (m, 2H), 7.50 (dd, J = 8.5, 2.7 Hz, 1H), 7.20 (d, J = 8.5 Hz, 1H), 7.06 (m, 2H),
5.27 (d, J = 12.2 Hz, 1H), 4.78 (d, J = 12.2 Hz, 1H), 4.24 (m, 2H), 3.94 (t, J = 6.2 Hz, 2H), 3.89
(m, 2H), 2.92 (t, J = 6.2 Hz, 2H), 2.83 (br. s, 4H), 1.35 (s, 9H). 13C NMR (126 MHz, CDCl3) δ ppm
168.90, 166.61, 161.81, 160.28, 152.59, 147.87, 143.90, 142.09, 140.49, 135.37, 130.96, 130.55,
121.87, 117.76, 117.36, 116.91, 114.56, 78.82, 69.41, 67.75, 65.98, 34.50, 32.25, 31.27, 25.52.
Rf 0.47 (20:1 DCM:MeOH).
16
3.6. Synthesis of Dihydrotetrazines
Dihydrotetrazine compounds were prepared based on known synthetic routes (30, 31).
3.6.1. 6-(6-(pyridine-2-yl)-1,4-dihydro-1,2,4,5-tetrazin-3-yl)pyridine-3-amine
2-cyanopyridine (3.00 g, 28.8 mmol, 2 eq.), 5-amino-2-cyanopyridine (1.71 g, 14.3 mmol, 1 eq.),
and hydrazine monohydrate (5 mL) were added to a 2-neck 100 mL round bottom flask with a stir
bar. The flask was equipped with a reflux condenser and purged with nitrogen. The reaction
mixture was brought to reflux under a nitrogen atmosphere, and the reaction was allowed to
proceed for 5 h. The reaction mixture was allowed to cool to room temperature, and then ice-cold
water (50 mL) was added. The solid was broken up into a powder with a spatula and collected by
filtration. The filtered solid was washed with ice cold water (50 mL), dried on the filter, and further
dried under vacuum. The crude product was redissolved in acetone and concentrated onto
deactivated silica gel1 in vacuo. A slurry of the adsorbed product in dichloromethane was added
to a wet-packed flash silica column. The desired product was eluted using a gradient of
dichloromethane to 20:1 dichloromethane:methanol. Fractions containing the desired product
were identified by thin layer chromatography, combined, and concentrated in vacuo to afford the
product as an orange solid (1.42 g, 5.6 mmol, 39.4% yield). 1H NMR (500 MHz, DMSO-d6) δ
ppm 8.73 (s, 1H), 8.67 (s, 1H), 8.62 (d, J = 4.9 Hz, 1H), 7.94 (m, 3H), 7.66 (d, J = 8.5 Hz, 1H),
7.51 (dd, J = 6.5, 5.2 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 5.90 (s, 2H). 13C NMR (126 MHz, DMSO-
1
Deactivated silica gel was prepared following a published protocol (32). Silica gel (100 g) was
added to a 500 mL recovery flask, suspended in anhydrous chloroform (200 mL), and cooled in
an ice bath. The flask was purged with nitrogen, and ethyltrichlorosilane (5.1 g, 4.2 mL) was
added dropwise via syringe, swirling the flask to mix. The suspension was allowed to return to
room temperature and allowed to stand at room temperature overnight with occasional swirling to
mix. The silica gel was filtered on a Buchner funnel and washed with chloroform (2 × 200 mL)
and methanol (5 × 200 mL). The silica gel was transferred to a 500 mL recovery flask and dried
by rotary evaporation. Deactivated silica gel was stored at room temperature.
17
d6) δ ppm 148.55, 147.50, 146.69, 146.65, 146.63, 137.33, 134.16, 134.08, 125.16, 121.85,
120.79, 120.28. Rf 0.36 (20:1 DCM:MeOH).
3.6.2. 3,6-di(pyridine-2-yl)-1,4-dihydro-1,2,4,5-tetrazine
The symmetric dipyridinyl dihydrotetrazine was synthesized as a by-product of the
reaction to produce the asymmetric aminopyridinyl dihydrotretrazine (see section
1.2.1). During silica column chromatography, fractions containing the symmetric
product were identified by thin layer chromatography, combined, and concentrated
in vacuo to afford the product as an orange solid (0.77 g, 3.2 mmol). 1H NMR (500
MHz, DMSO-d6) δ ppm 8.99 (s, 2H), 8.64 (m, 2H), 7.95 (m, 4H), 7.53 (ddd, J = 7.3,
4.9, 1.2 Hz, 2H). 13C NMR (126 MHz, DMSO-d6) δ ppm 148.63, 147.23, 146.30,
137.45, 125.38, 121.05. Rf 0.67 (20:1 DCM:MeOH).
18
3.6.3. 5-oxo-5-((6-(6-(pyridine-2-yl)-1,4-dihydro-1,2,4,5-tetrazin-3-yl)pyridine-3-
yl)amino)pentanoic acid
19
3.6.4. 2,5-dioxopyrrolidin-1-yl 5-oxo-5-((6-(6-(pyridine-2-yl)-1,4-dihydro-1,2,4,5-tetrazin-3-
yl)pyridine-3-yl)amino)pentanoate (“pyridyl-dHTz-NHS”)
5-oxo-5-((6-(6-(pyridine-2-yl)-1,4-dihydro-1,2,4,5-tetrazin-3-yl)pyridine-3-yl)amino)pentanoic acid
(1.36 g, 3.7 mmol, 1 eq.), N-hydroxysuccinimide (0.85 g, 7.4 mmol, 2 eq.), and N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (2.13 g, 11.1 mmol, 3 eq.) were added
to a 50 mL round bottom flask with a stir bar and dissolved in anhydrous DMF (15 mL). The flask
was purged with nitrogen, and the reaction was allowed to proceed for 2 h at room temperature.
The reaction mixture was diluted into 150 mL dichloromethane and washed with 1 M aqueous
lithium chloride (2 × 150 mL) and brine (150 mL). The organic phase was concentrated onto
deactivated silica gel in vacuo. The adsorbed crude product was loaded as a slurry in 10%
acetone in hexanes onto a wet-packed silica flash column. The product was eluted with a
gradient of 10%-90% acetone in hexanes. Fractions containing the desired product were
identified by thin layer chromatography, combined, and concentrated in vacuo to afford the
product as an orange solid (1.18 g, 2.5 mmol, 68.6% yield). 1H NMR (500 MHz, DMSO-d6) δ
ppm 10.42 (s, 1H), 8.93 (s, 1H), 8.87 (s, 1H), 8.83 (d, J = 1.7 Hz, 1H), 8.63 (d, J = 4.1 Hz, 1H),
8.16 (dd, J = 8.7, 1.8 Hz, 1H), 7.94 (m, 3H), 7.53 (m, 1H), 2.82 (s, 4H), 2.79 (t, J = 7.2 Hz, 2H),
2.53 (t, J = 7.4 Hz, 2H), 1.96 (quin, J = 7.3 Hz, 2H). 13C NMR (126 MHz, DMSO-d6) δ ppm
173.23, 170.71, 169.24, 149.06, 146.96, 146.82, 146.50, 141.93, 139.40, 137.89, 137.85, 127.19,
125.76, 121.84, 121.42, 35.00, 32.79, 25.93, 20.27. Rf 0.80 (70% acetone in hexanes).
20
3.7. Synthesis of Functionalized PEGs
3.7.1. 8-arm PEG-N3, 8-arm PEG-[4-N3/4-oNB-N3], 4-arm PEG-Sulfo-BCN
The detailed synthetic protocols and characterization of 8-arm PEG-N3, 8-arm PEG-[4-N3/4-oNB-
N3], and 4-arm PEG-Sulfo-BCN have been previously published (6). The 1H NMR spectra of the
final products are reproduced below.
PEG
CDCl3
a
b
b water
7 6 5 4 3 2 1 0
Chemical Shift (ppm)
21
b
d
a c e
f
g
h
j
k i d
a,g
a
CDCl3
PEG c,k
h
f b
j
CDCl3 i
3.25
Chemical Shift (ppm)
4.25 4.00
Chemical Shift (ppm)
8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
22
d,e,f
PEG
h
i g
c
j,k b water
m a
a
l c,d c,d
e,f e,f 2.50 2.25 2.00 1.75 1.50
Chemical Shift (ppm)
i k b a
l m h
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
23
3.7.2. 8-arm PEG-Sulfo-[4-BCN/4-pODIBO]
8-arm PEG-Sulfo-Boc
8-arm PEG-amine (1.00 g, MW ~ 20 kDa, 0.40 mmol -NH2, 1 eq.) was added to a 50 mL round
bottom flask with a stir bar and dissolved in anhydrous dimethylformamide (10 mL). In a separate
vial containing a stir bar, Boc-L-cysteic acid (430.9 mg, 1.60 mmol, 4 eq.) was dissolved in
anhydrous dimethylformamide (10 mL). After complete dissolution of the Boc-L-cysteic acid,
HATU (608.4 mg, 1.60 mmol, 4 eq.) was added and allowed to dissolve. N,N-
diisopropylethylamine (697 μL, 4.00 mmol, 10 eq.) was added, and the reaction was allowed to
proceed for 10 minutes at room temperature. The activated Boc-L-cysteic acid solution was
added dropwise to the stirring PEG solution, and the reaction was allowed to proceed overnight at
room temperature. The reaction mixture was diluted with water (60 mL) and dialyzed against
water (MWCO 2 kDa, 4 × 4 L, 4°C). The solution was flash frozen in liquid nitrogen and
lyophilized to afford the product as a slightly yellow solid (1.14 g, 0.052 mmol, 95% yield). 1H
NMR characterization is included below.
24
PEG
b
c a
a
g d,e a a
CDCl3
c e
f g b water
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
1H NMR (500 MHz, CDCl3) characterization for 8-arm PEG-Sulfo-Boc.
25
8-arm PEG-Sulfo-Amine
8-arm PEG-Sulfo-Boc (1.13 mg, MW ~ 22 kDa, 0.051 mmol) was dissolved in dichloromethane
(12.5 mL) and added to a 50 mL round bottom flask with a stir bar. While stirring,
triisopropylsilane (625 μL), water (625 μL), and trifluoroacetic acid (12.5 mL) were sequentially
added. The reaction was allowed to proceed for 4 h at room temperature. The reaction mixture
was concentrated by rotary evaporation, and the residue was added dropwise to ice cold diethyl
ether (80 mL) to precipitate the PEG. The PEG was collected by centrifugation, washed with cold
ether (2 × 50 mL), and dried under a stream of compressed air. The solid was re-dissolved in
water (20 mL) and dialyzed against water (MWCO 2 kDa, 4 × 4 L, 4°C). The solution was flash
frozen in liquid nitrogen and lyophilized to afford the product as a white solid (895 mg, 0.042
mmol, 82% yield). 1H NMR characterization is included below.
26
PEG
a
DMSO-d6
b,c
e
d
c b
a
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
1H NMR (500 MHz, DMSO-d6) characterization for 8-arm PEG-Sulfo-amine.
27
8-arm PEG-Sulfo-[4-BCN/4-pODIBO]
BCN-NHS (8.24 mg, 0.028 mmol, 0.75 eq.) and pODIBO-NHS (14.7 mg, 0.028 mmol, 0.75 eq.)
were added to a 25 mL round bottom flask containing a stir bar. 8-arm PEG-Sulfo-amine (100
mg, MW ~ 21.2 kDa, 0.038 mmol -NH2, 1 eq.) was dissolved in anhydrous DMF (2 mL) and
added to the flask. After complete dissolution of the reagents, N,N-diisopropylethylamine (39.4
μL, 0.226 mmol, 6.0 eq.) was added, and the reaction was allowed to proceed overnight at room
temperature. The reaction mixture was diluted to 20 mL with water and dialyzed against water
(MWCO 2 kDa, 3 × 4 L, 4°C). The solution was flash frozen in liquid nitrogen and lyophilized to
afford the product as a white solid. The ratio of conjugated BCN:pODIBO was estimated to be
~1:1.0 based on integration of the corresponding 1H NMR signals. 1H NMR characterization is
included below.
28
a
b g
c,d b
e a
a
f c,d c,d
e,f e,f
b
e l
c,d g h
i d,e,f
f k
j b a
l
a
f
e
d c a
c
PEG
b a
8.00 7.75 7.50 7.25 7.00
Chemical Shift (ppm)
g 1.25 1.00
k
Chemical Shift (ppm)
i j
e b
c
d
5.25 5.00 4.75 4.50 4.25 4.00
Chemical Shift (ppm)
3.25 3.00
CDCl3
Chemical Shift (ppm)
f a
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
29
3.7.3. mPEG-dHTz
Methoxy-PEG-amine (100 mg, MW ~ 2kDa, 0.05 mmol -NH2, 1 eq.) and pyridyl-dHTz-NHS (34.8
mg, 0.075 mmol, 1.5 eq.) were added to a 25 mL round bottom flask with a stir bar and dissolved
in anhydrous dimethylformamide (3 mL). N,N-diisopropylethylamine (34.8 μL, 0.20 mmol, 4 eq.)
was added, and the reaction was allowed to proceed overnight at room temperature. The PEG
was precipitated by dropwise addition to ice cold diethyl ether (45 mL) and collected by
centrifugation. The supernatant was decanted, and the pellet was washed with cold ether (25
mL), dried under a stream of compressed air, and re-dissolved in dichloromethane (5 mL). The
solution was washed with water (2.5 mL) and brine (2.5 mL) and concentrated to ~ 2 mL. The
product was precipitated by dropwise addition to ice cold diethyl ether (45 mL) and collected by
centrifugation. The supernatant was decanted, and the pellet was washed with cold ether (2 × 25
mL), dried under a stream of compressed air, and re-dissolved in water (5 mL). The solution was
flash frozen in liquid nitrogen and lyophilized to afford the product as an orange solid (85 mg,
0.036 mmol, 72.3% yield). 1H NMR characterization is included below.
30
b
a c PEG
d o
e
f
g
n i h
m k
o j
l
CDCl3 k m
d,g
l
a e,f,i b
c h
j n water
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
31
3.7.4. 8-arm PEG-[4-N3/4-dHTz]
8-arm PEG-amine (400 mg, MW ~ 10 kDa, 0.32 mmol -NH2, 1 eq.), azidoacetic acid NHS ester
(34.8 mg, 0.176 mmol, 0.55 eq.), and pyridyl-dHTz-NHS (148.6 mg, 0.32 mmol, 1 eq.) were
added to a 25 mL round bottom flask with a stir bar and dissolved in anhydrous
dimethylformamide (4 mL). N,N-diisopropylethylamine (223 μL, 1.28 mmol, 4 eq.) was added,
and the reaction was allowed to proceed overnight at room temperature. The PEG was
precipitated by dropwise addition to ice cold diethyl ether (45 mL) and collected by centrifugation.
The supernatant was decanted, and the pellet was broken up with a spatula and washed with
cold ether (25 mL), dried under a stream of compressed air, and re-dissolved in dichloromethane
(5 mL). The solution was washed with water (2 × 2.5 mL) and brine (2.5 mL). The product was
precipitated by dropwise addition to ice cold diethyl ether (45 mL) and collected by centrifugation.
The supernatant was decanted, and the pellet was washed with cold ether (2 × 25 mL), dried
under a stream of compressed air, and re-dissolved in water (6 mL). The solution was flash
frozen in liquid nitrogen and lyophilized to afford the product as an orange solid (304 mg, 0.026
mmol, 65% yield). The ratio of conjugated dHTz:azide was estimated to be 1:1.47 based on
integration of the corresponding 1H NMR signals. 1H NMR characterization is included below.
32
l
j PEG
m k
n i h
g
f
b a
e
d
a c
b a
e,f,i d,g CDCl3
k m
b l
a h
c b water
j n
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
33
3.7.5. IRDye700DX-PEG-Azide
A solution of Azide-PEG-Amine (MW ~ 3.5 kDa, 18 mg/mL) was prepared in anhydrous DMF.
The PEG solution (50 μL, 0.9 mg, 1 eq.) was added to a vial containing IRDye700DX-NHS (0.5
mg, 1 eq.) and mixed by pipetting. Excess N,N-diisopropylethylamine (1 μL, ~22 eq.) was added
and mixed by pipetting. The reaction was transferred to a fresh microcentrifuge tube and agitated
at 500 rpm overnight at room temperature. The reaction mixture was diluted with 250 μL MilliQ-
grade water and dialyzed against MilliQ-grade water (MWCO 0.5-1 kDa, 4 × 1 L, 4°C). The
dialyzed solution was flash frozen in liquid nitrogen and lyophilized to afford the product as a
blue/turquoise solid in quantitative yield. A stock solution of the dye conjugate was prepared by
dissolving the product in MilliQ-grade water to 10 mM. MALDI-TOF mass spectral and UV-Vis-
NIR spectral characterization are included below.
34
1.00
Normalized Count (a.u.)
0.75 4429.85
0.50
0.25
0.00
2000 3500 5000 6500 8000
Mass (m/z)
0.5
0.0
300 400 500 600 700 800
Wavelength (nm)
35
Supporting Figures
Fig. S1. UV light exposure alone does not alter cell fate. (A) The proliferative fraction and (B)
progenitor fraction of cells at day 7 is not significantly altered by exposure to the same dose of UV
light used in the softening and stiffening hydrogel experiments. Data are presented as mean ±
s.d. *p<0.05, ***p<0.001, ns = not significant.
36
No i t nm
3.4
Relative Elastic
Modulus
1 m
0.9
Fig. S2. Spatial stiffness and swelling characterization for softening hydrogels. (A)
Representative heat map of AFM-measured relative stiffness for 10 μm x 10 μm areas of oNB-
based hydrogels before and after exposure to 365 nm light. (B) Consistent with the bulk
rheological characterization, exposure to light results in a ~3-fold decrease in elastic modulus,
with measured values consistent between independent samples. (C) Samples exhibit locally
homogeneous stiffness over 10 μm x 10 μm areas, as demonstrated by standard deviations of
the elastic moduli that comprise less than 3% of the absolute value of the mean stiffness of the
sample. (D) Samples also exhibit spatial homogeneity over larger length scales, as indicated by
consistent average moduli measured at disparate regions of the same gel. (E) The surface of the
gels does not exhibit buckling due to swelling post-irradiation, as the standard deviation of the
surface height from AFM measurements does not differ before and after light exposure. (F) Bulk
swelling ratio measurements confirm the gels do not substantially swell after softening. Data are
presented as mean ± s.d. ***p<0.001, ns = not significant.
37
So t Sti
50 m
Laminin Cy5
No i t nm
50 m
Laminin Cy5
Fig. S3. Laminin presentation is consistent across hydrogel conditions. (A) Representative
confocal micrographs of fluorescently labeled laminin-PEG-azide incorporated in static soft and
stiff hydrogels. (B) The laminin content, as measured by the relative fluorescence intensity, does
not significantly vary between the soft and stiff hydrogels. (C) Representative confocal
micrographs of fluorescently labeled laminin-PEG-azide incorporated in softening (oNB-based)
hydrogels with and without exposure to 365 nm light. (D) The laminin content, as measured by
the relative fluorescence intensity, does not significantly vary after light-triggered softening. Data
are presented as mean ± s.d. ns = not significant.
38
yo eni a tor ti ation ar er
Fig. S4. Single cell data for immunofluorescence staining of the myogenic factors (A) Pax7 and
(B) MyoD and the activation markers (C) Ki67 and (D) phosphorylated p38 MAP kinase (P-p38).
The dashed lines represent the fluorescence intensity threshold used to determine cells staining
positive for these markers, as reported in Fig. 2C-F.
39
Fig. S5. Photo-SPAAC triggered stiffening is stable under cell culture conditions. (A) Reaction
schematic of the photo-SPAAC reaction. (B) Idealized schematic of PEG-based hydrogel
40
networks that can be stiffened on demand by light exposure via photo-SPAAC. (C,D) UV-visible
light spectroscopy analysis of pODIBO-functionalized PEGs dissolved in DMEM plus 10% FBS
and maintained at 37°C for 3 weeks does not show any noteworthy decomposition of the
pODIBO. (E,F) After 3 weeks in in DMEM plus 10% FBS at 37°C, pODIBO is still able to undergo
rapid photoactivation, as observed in UV-visible light spectroscopy analysis upon exposure to 365
nm light. (G) PEG hydrogels containing pODIBO groups and excess azides maintain their initial
stiffness over the course of 1 week under MuSC culture conditions (DMEM plus 15% FBS at
37°C) as well as their ability to stiffen on demand by exposure to 365 nm light. Data are
presented as mean ± s.d. ***p<0.001, n.s. = not significant.
41
H
42
tetrazine ligation reaction. (B) Idealized schematic of PEG-based hydrogel networks that can be
stiffened on demand by light exposure via photo-catalyzed tetrazine ligation. (C) Photooxidation
by soluble methylene blue resulted in substantial cell death, while (D) photooxidation by hydrogel
tethered IRDye 700DX resulted in no appreciable loss in cell viability. (E) UV-Vis spectroscopy
analysis of photooxidation of PEG-conjugated dihydrotetrazine (dHTz) to tetrazine (Tz) upon
exposure to 680 nm LED light for varying amounts of time. (F) Reaction kinetics of dHTz
photooxidation. (G) Hydrogels containing dHTz, conjugated IRDye 700DX, and excess BCN
groups stiffen upon exposure to 680 nm LED light. (H) UV-Vis spectroscopy analysis of PEG-
conjugated dHTz revealed spontaneous oxidation to tetrazine (Tz) upon exposure to serum-
containing cell culture medium, indicating this chemistry is not suitable for multi-day cell culture
experiments.
43
No i t nm
3.7
Relative Elastic
Modulus
1 m
0.9
H
No i t nm
50 m
Laminin Cy5
Fig. S7. Characterization of pODIBO hydrogels pre- and post- stiffening. (A) Representative heat
map of AFM-measured relative stiffness for 10 μm x 10 μm areas of pODIBO-based hydrogels
before and after exposure to 365 nm light. (B) Consistent with the bulk rheological
characterization, exposure to light results in a ~3-fold increase in elastic modulus, with measured
values consistent between independent samples. (C) Samples exhibit locally homogeneous
stiffness over 10 μm x 10 μm areas, as demonstrated by standard deviations of the elastic moduli
that comprise less than 3% of the absolute value of the mean stiffness of the sample. (D)
Samples also exhibit spatial homogeneity over larger length scales, as indicated by consistent
average moduli measured at disparate regions of the same gel. (E) The surface of the gels does
not exhibit buckling due to de-swelling post-irradiation, as the standard deviation of the surface
height from AFM measurements does not differ before and after light exposure. (F) Bulk swelling
ratio measurements indicate a moderate degree of de-swelling after light exposure due to the
44
addition of new crosslinks in the network. (G) Representative confocal micrographs of
fluorescently labeled laminin-PEG-azide incorporated in stiffening (pODIBO-based) hydrogels
with and without exposure to 365 nm light. (H) The laminin content, as measured by the relative
fluorescence intensity, does not significantly vary after light-triggered stiffening. Data are
presented as mean ± s.d. ***p<0.001, ns = not significant.
45
Sin le ell N Se en in
MAP2
MAP2
MAP2
MAP2
MAP2
MAP2
0 0 0 0 0 0
MAP1 MAP1 MAP1 MAP1 MAP1 MAP1
MAP2
MAP2
MAP2
MAP2
1 2
2 2
2
MAP1 MAP1 MAP1 MAP1 MAP1
Fig. S8. UMAP projections overlaid with expression levels for (A) myogenic genes for single cell
RNA sequencing analysis and (B) cell fate markers for single cell protein immunofluorescence
analysis.
46
Sin le ell N Se en in Sin le ell rotein mm no l ore en e
o n ed o n ed
1.0 1.0
Relative Density
Relative Density
0.8 0.8
0.6 0.6
MAP2
MAP2
So t
So t
0.4 0.4
0.2 0.2
0.0 0.0
1.0 1.0
Relative Density
Relative Density
0.8 0.8
MAP2
MAP2
0.6 0.6
Sti
Sti
0.4 0.4
0.2 0.2
0.0 0.0
MAP1 MAP1 MAP1 MAP1
Fig. S9. Young (2 mo) and aged (>24 mo) cells distribute into the same clusters as a function of
substrate stiffness, demonstrated here by similar distributions on the UMAP projections,
indicating that aged MuSCs are still capable of mechanosensing similar to young MuSCs at day 7
of culture, by both (A) single cell RNA sequencing and (B) single cell protein
immunofluorescence.
47
Fraction of Total Cells
Stiff+
Rho
Soft
Soft
Soft
Soft
Soft
Stiff
Stiff
Soft
Stiff
Stiff
Stiff
Stiff
Young Aged Young Aged Young Aged
Fig. S10. (A) UMAP projection of single cell RNA sequencing data with annotated cell fate
clusters. (B) Fraction of cells in each cell fate cluster as a function of time point and experimental
condition. Similar trends are observed between soft and stiff culture substrates for both young
and aged MuSCs. Treatment with Rho inhibitor (Rhoi) for 3 days on stiff substrates results in a
distribution of cells more similar to cells cultured on soft substrates than stiff substrates at day 3.
48
SI References
2. S. C. Schüler, et al., Extracellular matrix: Brick and mortar in the skeletal muscle stem cell
niche. Front. Cell Dev. Biol. 10, 1056523 (2022).
3. S. S. Rayagiri, et al., Basal lamina remodeling at the skeletal muscle stem cell niche
mediates stem cell self-renewal. Nat. Commun. 9, 1075 (2018).
5. P. M. Gilbert, et al., Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal
in Culture. Science 329, 1078–1081 (2010).
7. J. Wang, et al., Engineered skeletal muscles for disease modeling and drug discovery.
Biomaterials 221, 119416 (2019).
14. A. Mo, et al., Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain. Neuron
86, 1369–1384 (2015).
15. S. Southard, et al., A series of Cre-ER(T2) drivers for manipulation of the skeletal muscle
lineage. Genes. N. Y. N 2000 52, 759–770 (2014).
49
17. J. S. Silver, et al., Injury-mediated stiffening persistently activates muscle stem cells through
YAP and TAZ mechanotransduction. Sci. Adv. 7, eabe4501 (2021).
19. C. M. Madl, et al., Maintenance of neural progenitor cell stemness in 3D hydrogels requires
matrix remodelling. Nat Mater 16, 1233–1242 (2017).
20. A. Salic, T. J. Mitchison, A chemical method for fast and sensitive detection of DNA
synthesis in vivo. Proc Natl Acad Sci USA 105, 2415–2420 (2008).
21. S. Eliazer, et al., Wnt4 from the Niche Controls the Mechano-Properties and Quiescent
State of Muscle Stem Cells. Cell Stem Cell 25, 654–665 (2019).
23. M. Y. Lee, et al., CellSeg: a robust, pre-trained nucleus segmentation and pixel
quantification software for highly multiplexed fluorescence images. BMC Bioinformatics 23,
46 (2022).
24. A. B. Rosenberg, et al., SPLiT-seq reveals cell types and lineages in the developing brain
and spinal cord. Science 360, 176–182 (2018).
25. F. A. Wolf, P. Angerer, F. J. Theis, SCANPY: large-scale single-cell gene expression data
analysis. Genome Biol. 19, 15 (2018).
28. K. Brooks, et al., Multifunctional Surface Manipulation Using Orthogonal Click Chemistry.
Langmuir 32, 6600–6605 (2016).
29. S. V. Orski, et al., High Density Orthogonal Surface Immobilization via Photoactivated
Copper-Free Click Chemistry. J Am Chem Soc 132, 11024–11026 (2010).
30. H. Zhang, et al., Rapid Bioorthogonal Chemistry Turn-on through Enzymatic or Long
Wavelength Photocatalytic Activation of Tetrazine Ligation. J Am Chem Soc 138, 5978–
5983 (2016).
50